Safeguard Scientifics Leads $21M Round for Putney
Specialty pharmaceutical company Putney has raised $21 million in new financing co-led by listed Safeguard Scientifics Inc. NewSpring Health Capital and other, undisclosed investors also contributed. Safeguard Scientifics put $10 million into the Series C round, which will be used to bolster sales and marketing. Portland, Maine-based Putney develops generic medicines for pets.
29 September 2011•7 mins read
